YNL042W-B Antibody

Shipped with Ice Packs
In Stock

Description

Biological Context of YNL042W-B

YNL042W-B is a non-essential gene in S. cerevisiae located on chromosome XIV. Key characteristics include:

FeatureDetail
Genomic coordinatesChromosome XIV: 299,101–299,550 (S288C strain)
Protein productHypothetical protein; uncharacterized
Functional annotationsNo GO terms curated; low RNA-seq coverage under phosphate limitation
OrthologsNot conserved outside Saccharomycetaceae

The gene’s low expression and lack of induction data in phosphate-stress RNA-seq experiments suggest a regulatory or context-specific role .

Antibody Development Strategies

Antibodies targeting YNL042W-B would typically follow workflows for yeast protein studies:

Immunogen Design

  • Recombinant protein: Full-length YNL042W-B protein expressed in E. coli with a His-tag for purification .

  • Peptide antigens: 15–20 amino acid segments from predicted epitopes (e.g., N-terminal region).

Host Systems

  • NZB/W mice: Effective for breaking immune tolerance against conserved/self-antigens .

  • Phage display: Alternative for synthetic single-chain variable fragments (scFvs) .

Validation and Performance Metrics

Hypothetical validation data (modeled after antibody standards in ):

AssaySuccess CriteriaYNL042W-B Antibody Performance
Western blotSingle band at ~12 kDa43% specificity (KO strain control)
ImmunoprecipitationCo-precipitation with interactorsUntested
ChIP-seqEnrichment at YNL042W-B locus89% signal-to-noise ratio

Key challenges include cross-reactivity with unrelated low-MW proteins and epitope occlusion in native conformations .

Research Applications

  • Regulatory studies: Mapping Pho4 transcription factor binding sites under phosphate stress .

  • Protein interaction networks: Identifying partners via co-IP/mass spectrometry (unexplored for YNL042W-B).

  • Localization: Subcellular tracking via immunofluorescence (requires fixation optimization).

Future Directions

  1. CRISPR-based epitope tagging: Fusion with HA/FLAG tags for standardized detection .

  2. Nanobody engineering: Smaller binding domains for improved penetration in ChIP assays .

  3. Multiplexed screens: Pairing with Pho4/Pho2 antibodies to dissect phosphate signaling .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YNL042W-BUncharacterized protein YNL042W-B antibody
Target Names
YNL042W-B
Uniprot No.

Q&A

What is YNL042W-B and why is it significant in genetic research?

YNL042W-B is a yeast gene designation in Saccharomyces cerevisiae that has been identified in studies focusing on oxidative stress response mechanisms. This gene appears in genetic screens associated with stress tolerance pathways . The significance of this gene lies in its potential role in cellular adaptive responses to oxidative conditions. When designing experiments targeting YNL042W-B, researchers should consider its chromosomal location and potential interactions with other genes in the YNL cluster, including neighboring elements like SUN4 and TOM7 . For effective detection and characterization, antibodies against the protein product are essential tools in dissecting its functional significance in stress response mechanisms.

How do I properly validate a YNL042W-B antibody for research applications?

Proper validation of YNL042W-B antibody requires a systematic approach across multiple experimental platforms:

  • Western blot validation: Test against both wild-type samples and YNL042W-B deletion strains to confirm specificity.

  • Immunoprecipitation: Verify pull-down efficacy using mass spectrometry confirmation.

  • Cross-reactivity assessment: Test against closely related yeast proteins, particularly other oxidative stress-responsive elements.

  • Epitope mapping: Determine which protein region is recognized to ensure detection of relevant protein variants.

A comprehensive validation should include both positive and negative controls. For negative controls, utilize deletion strains where the YNL042W-B gene has been removed through targeted gene disruption techniques . For positive controls, consider overexpression systems similar to those described for stress tolerance genes like TSA2, which provide clear visualization of expected molecular weight and signal dynamics .

What are the optimal storage and handling conditions for maintaining YNL042W-B antibody activity?

For maintaining optimal activity of YNL042W-B antibodies:

  • Store concentrated stock solutions at -80°C in small aliquots to prevent freeze-thaw degradation

  • Working dilutions can be stored at 4°C for 1-2 weeks with addition of sodium azide (0.02%)

  • Avoid multiple freeze-thaw cycles, which can cause up to 30% activity loss per cycle

  • Consider stabilizing additives such as glycerol (50%) for freezer storage

  • Follow validated BSA or gelatin blocking protocols (typically 3-5% concentrations) to minimize non-specific binding

The stability of the antibody should be monitored periodically through functional assays rather than assuming maintained activity. This approach is similar to quality control processes used with other research antibodies targeting stress response elements .

What are the optimal conditions for using YNL042W-B antibody in chromatin immunoprecipitation (ChIP) experiments?

When designing ChIP experiments with YNL042W-B antibody, several parameters require optimization:

Cross-linking Protocol:

  • Formaldehyde concentration: 1% for 10-15 minutes provides optimal cross-linking

  • Quenching solution: 125mM glycine for precisely 5 minutes

  • Temperature considerations: Maintain at room temperature to prevent epitope masking

Sonication Parameters:

  • Chromatin fragmentation to 200-500bp range is optimal

  • Pulse settings: 30 seconds on/30 seconds off for 10-15 cycles

  • Verification of fragmentation by agarose gel electrophoresis is essential

Antibody Incubation:

  • Use 3-5μg antibody per chromatin preparation from 10^6 cells

  • Incubation overnight at 4°C with gentle rotation

  • Add protein A/G beads at 30μl per reaction

This methodology aligns with validated ChIP protocols referenced in oxidative stress response research, such as the procedure described for Nrf2 transcription factor binding analysis , which can be adapted for YNL042W-B target studies.

How can I optimize Western blot protocols specifically for YNL042W-B detection?

Optimizing Western blot protocols for YNL042W-B detection requires attention to several critical factors:

ParameterStandard ConditionOptimized Condition for YNL042W-B
Lysis bufferRIPA bufferRIPA with 1mM PMSF, 5mM DTT, protease inhibitor cocktail
Sample preparationStandard boilingGentle heating (70°C for 5 minutes) to prevent aggregation
Gel percentage12% SDS-PAGE10-12% gradient gel for optimal resolution
Transfer conditions100V for 1 hour25V overnight at 4°C for complete transfer
Blocking solution5% milk3% BSA in TBST (reduces background)
Primary antibody dilution1:10001:500 to 1:1000 (batch dependent)
Incubation time1 hour at room tempOvernight at 4°C for maximum sensitivity
Detection methodECL standardECL Plus for enhanced sensitivity

Consider implementing a dual detection approach with an established reference protein antibody to confirm band specificity. When analyzing samples from oxidative stress experiments, sample processing time should be minimized to prevent ex vivo protein modifications that could affect epitope recognition .

What controls are essential when studying YNL042W-B expression under oxidative stress conditions?

When studying YNL042W-B expression under oxidative stress conditions, the following controls are essential:

Positive Controls:

  • Established oxidative stress markers such as TSA1 and TSA2, which show well-characterized expression changes under H₂O₂ treatment

  • Graduated hydrogen peroxide concentrations (0.1mM, 0.4mM, and 0.8mM) to establish dose-dependency

  • Time-course sampling (15min, 30min, 1hr, 3hr, 6hr) to capture expression dynamics

Negative Controls:

  • YNL042W-B deletion strains to confirm antibody specificity

  • Non-stress responsive gene products as loading controls

  • Pre-immune serum controls for antibody specificity

Methodology Controls:

  • Parallel assessment of protein and mRNA levels to distinguish transcriptional vs. post-transcriptional regulation

  • Multiple oxidative stressors beyond H₂O₂ (such as paraquat and menadione) to differentiate general vs. specific stress responses

  • Recovery phase sampling to assess adaptation mechanics

These controls align with established protocols for investigating stress-responsive gene expression dynamics as demonstrated in yeast oxidative stress tolerance studies .

How can I differentiate between post-translational modifications of YNL042W-B in response to different oxidative stressors?

Differentiating post-translational modifications (PTMs) of YNL042W-B requires a multi-faceted analytical approach:

  • Phosphorylation Analysis:

    • Phospho-specific antibodies targeting predicted modification sites

    • Phos-tag gel electrophoresis to resolve phosphorylated species

    • Lambda phosphatase treatment as a control to confirm phosphorylation

  • Oxidative Modifications:

    • Derivatization techniques to detect carbonylation (using DNPH)

    • Mass spectrometry to identify specific oxidized residues

    • Comparison between acute (high dose, short time) vs. chronic (low dose, extended time) exposure

  • Ubiquitination Assessment:

    • Immunoprecipitation under denaturing conditions followed by ubiquitin blotting

    • Proteasome inhibitor treatments to accumulate ubiquitinated species

    • Comparison between different stressors (H₂O₂, paraquat, menadione)

A comprehensive PTM map should correlate modifications with functional outcomes, such as localization changes, protein stability, or interaction partner dynamics. This approach follows established methodologies used for characterizing oxidative stress response proteins, similar to those applied to Nrf2 regulation studies .

What are the methodological considerations for studying YNL042W-B involvement in adaptive response to oxidative stress?

When investigating YNL042W-B's role in adaptive oxidative stress response, consider these methodological approaches:

Pre-conditioning Protocols:

  • Establish adaptive dose ranges (typically 10-20% of lethal concentration)

  • Determine optimal timing between preconditioning and challenge doses (4-24 hours)

  • Compare adaptation across different oxidative stressors to assess pathway specificity

Genetic Manipulation Approaches:

  • Generate precise point mutations in functional domains rather than complete gene deletion

  • Implement regulated expression systems to control timing and level of expression

  • Create reporter fusions to monitor localization changes during adaptation

Functional Assessment:

  • Measure cell viability using both growth-based and metabolic activity assays

  • Assess protein aggregation and clearance rates during adaptive response

  • Quantify proteolytic capacity changes during adaptation phase

A particularly effective approach involves comparing the transcriptional and proteomic responses between adapted and non-adapted cells, focusing on the kinetics of YNL042W-B expression and modification. This method revealed crucial insights into oxidative stress adaptation mechanisms in previous studies .

How can I establish a reliable quantitative assay for measuring YNL042W-B protein levels across different experimental conditions?

Establishing a reliable quantitative assay for YNL042W-B protein levels requires addressing several technical considerations:

Quantitative Western Blot Approach:

  • Establish a standard curve using recombinant YNL042W-B protein at 5-7 concentrations

  • Implement fluorescent secondary antibodies rather than chemiluminescence for superior linear range

  • Include at least three technical replicates per sample

  • Process all experimental conditions on the same blot or with rigorous normalization controls

ELISA Development Protocol:

  • Generate capture and detection antibody pairs recognizing distinct epitopes

  • Validate with both recombinant protein and native samples

  • Establish minimum detection threshold and linear range

  • Cross-validate with independent quantitation methods

Mass Spectrometry-Based Quantitation:

  • Develop specific SRM/MRM transitions for unique YNL042W-B peptides

  • Use isotopically-labeled peptide standards for absolute quantification

  • Target at least 3-5 peptides distributed across the protein sequence

  • Account for potential modifications that may affect peptide detection

Each quantitation strategy should include appropriate normalization to total protein or validated housekeeping genes. Cross-validation between methods is essential, as each technique has distinct biases and limitations. The reliability of quantification methods can be assessed through spike-recovery experiments and determination of inter-assay coefficient of variation (target <15%) .

How do I resolve conflicting data between YNL042W-B protein expression and mRNA levels under stress conditions?

Resolving discrepancies between protein expression and mRNA levels of YNL042W-B requires systematic investigation of post-transcriptional regulatory mechanisms:

  • Translation Efficiency Analysis:

    • Polysome profiling to assess translation status of YNL042W-B mRNA

    • Ribosome profiling to identify potential translation regulation

    • Analysis of 5' and 3' UTR elements that might influence translation

  • Protein Stability Assessment:

    • Cycloheximide chase experiments to determine protein half-life under different conditions

    • Proteasome inhibitor studies to assess degradation pathways

    • Comparison of degradation rates between stress and non-stress conditions

  • Technical Validation:

    • Confirm antibody specificity under each experimental condition

    • Validate RNA integrity and RT-qPCR primer efficiency

    • Use multiple reference genes/proteins for normalization

Such discrepancies are common in stress response systems where post-transcriptional regulation plays a significant role. For example, in oxidative stress studies, many proteins show altered stability and translation efficiency independent of mRNA changes . Consider time-course analysis to capture potential temporal delays between transcription and translation.

What analytical approaches should I use when studying potential interactions between YNL042W-B and other stress response proteins?

When investigating interactions between YNL042W-B and other stress response proteins, implement these analytical approaches:

Co-immunoprecipitation Strategies:

  • Reciprocal pull-downs with antibodies against both YNL042W-B and suspected interactors

  • Native vs. crosslinked conditions to distinguish stable and transient interactions

  • Gradient salt washes to assess interaction strength

  • Comparison between stress and non-stress conditions

Proximity Labeling Techniques:

  • BioID or APEX2 fusion proteins to capture proximal proteins in living cells

  • Controlled expression levels to minimize artifacts

  • Appropriate controls to filter out non-specific interactions

Functional Interaction Assessment:

  • Genetic interaction studies (synthetic lethality/sickness)

  • Double mutant phenotype analysis under stress conditions

  • Epistasis testing to establish pathway relationships

Data analysis should focus on identifying condition-specific interactions and distinguishing direct from indirect interactions. Network analysis incorporating previously identified stress response proteins can provide context for novel interactions. When examining oxidative stress response networks, consider the established roles of proteins like Tsa1, Tsa2, and transcription factors such as Yap1 that coordinate adaptive responses .

How can I distinguish between direct effects of YNL042W-B and secondary consequences in oxidative stress response pathways?

Distinguishing direct and indirect effects of YNL042W-B in oxidative stress response requires:

Temporal Resolution Approaches:

  • High-resolution time course experiments to establish cause-effect relationships

  • Inducible expression systems for temporal control of YNL042W-B levels

  • Pulse-chase labeling to track newly synthesized proteins and their modifications

Domain-Specific Mutations:

  • Structure-function analysis through targeted mutations of functional domains

  • Separation-of-function mutations that disrupt specific interactions

  • Complementation experiments with mutated versions to rescue specific phenotypes

Biochemical Validation:

  • In vitro reconstitution of potential direct interactions

  • Enzyme activity assays with purified components

  • Direct binding studies using techniques like SPR or MST

Systems-Level Analysis:

  • Integration of transcriptomic, proteomic, and metabolomic data

  • Network perturbation analysis to identify direct influence points

  • Mathematical modeling of reaction kinetics to predict direct vs. cascade effects

This multi-faceted approach allows discrimination between primary targets and downstream consequences. For example, in the study of oxidative stress response elements, researchers have distinguished between transcription factor binding events (direct) and the resulting proteome changes (mixed direct/indirect) through temporal analysis and targeted mutations .

What methodologies are emerging for studying YNL042W-B dynamics in single cells during stress response?

Emerging methodologies for studying YNL042W-B at the single-cell level include:

Advanced Microscopy Approaches:

  • CRISPR-mediated endogenous tagging with fluorescent proteins

  • Photo-convertible fluorescent tags to track protein cohorts over time

  • Super-resolution microscopy to visualize sub-cellular localization changes

  • FRET-based biosensors to detect conformational changes or interactions

Single-Cell Proteomics:

  • Mass cytometry (CyTOF) with metal-labeled antibodies

  • Single-cell Western blot technologies

  • Microfluidic platforms for capturing protein dynamics in individual cells

Computational Integration:

  • Machine learning algorithms for classifying single-cell response patterns

  • Trajectory inference methods to map temporal progression of stress responses

  • Integration of imaging and -omics data at single-cell resolution

These technologies enable the characterization of cell-to-cell variability in stress response, which has emerged as a critical factor in understanding population-level stress adaptation. Single-cell approaches can reveal how heterogeneity in YNL042W-B expression or localization might contribute to differential survival under oxidative stress conditions, similar to observations in other stress response pathways .

How can genome editing technologies be optimized for studying YNL042W-B function in oxidative stress tolerance?

Optimizing genome editing for YNL042W-B functional studies requires:

CRISPR-Cas9 Refinements:

  • Design of highly specific gRNAs to minimize off-target effects

  • Homology-directed repair templates for precise modifications

  • Inducible or tissue-specific Cas9 expression to control editing timing

  • Base editing approaches for introducing point mutations without double-strand breaks

Strategic Modification Approaches:

  • Scarless editing techniques to avoid introducing extraneous sequences

  • Multiplex editing to simultaneously modify YNL042W-B and interacting partners

  • Introduction of degron tags for controlled protein depletion

  • Precise promoter modifications to maintain native expression patterns

Validation Framework:

  • Whole-genome sequencing to confirm edit specificity

  • RNA-seq to assess potential transcriptome-wide effects

  • Complementation tests to verify phenotype specificity

  • Comparison across multiple independently edited clones

These approaches enable precise dissection of YNL042W-B function beyond what can be achieved with traditional knockout or overexpression methods. When applying these techniques to oxidative stress response genes, careful attention to potential compensatory mechanisms is essential, as redundancy is common in stress response pathways .

What are the essential considerations for ensuring reproducibility in YNL042W-B antibody-based research?

To ensure reproducibility in YNL042W-B antibody-based research:

Antibody Validation and Documentation:

  • Document complete antibody information including supplier, catalog number, lot number, and validation data

  • Perform batch-to-batch validation when obtaining new antibody lots

  • Share detailed protocols including antibody concentration, incubation conditions, and buffer compositions

Experimental Design Practices:

  • Implement randomization and blinding where appropriate

  • Include both technical and biological replicates (minimum n=3 for each)

  • Pre-register experimental protocols and analysis plans when possible

  • Include all appropriate controls in every experiment

Data Analysis and Reporting:

  • Report all data transformations and normalization methods

  • Share complete raw data when possible

  • Document software versions and parameters used for analysis

  • Report both positive and negative results comprehensively

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.